Lapsed Jun 3, 2026 on the fee record · High confidence
20-year base term ends Jan 21, 2031
Third maintenance fee unpaid; grace period ended.
Held by Medtimo Inc.
Filed May 18, 2012 as application 13/510,921 · Granted Jun 3, 2014
Base term, 20 years from filing
Today
Lapsed Jun 3, 2026
2011
2031
Clock starts
Jan 21, 2011
Jan 21, 2011
No longer in force
Jun 3, 2026
Jun 3, 2026
Granted
Jun 3, 2014
Jun 3, 2014
Term would have run to
Jan 21, 2031
Jan 21, 2031
base term
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
13
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Jan 21, 2031: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 21, 2011, when application PCT/US2011/022165, the earliest non-provisional in its chain, was filed (this one was filed May 18, 2012) | Jan 21, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Jun 3, 2026 | High confidence |
| Computed term end | The steps above, in order | Jun 3, 2026 | High confidence |
This family
| Application PCT/US2011/022165 | PCT application no patent term | no patent term |
| US 8,740,927 | this patent Jun 2026 | Jun 2026 |
| US 9,351,862 | In force Jan 2031 | Jan 2031 |
| US 9,827,128 | Lapsed on the fee record Nov 2025 | Nov 2025 |
| US 9,662,239 | In force Jan 2031 | Jan 2031 |
| US 10,463,520 | In force Sep 2031 | Sep 2031 |
| US 10,610,396 | In force Jun 2031 | Jun 2031 |
| US 11,737,899 | In force Jul 2032 | Jul 2032 |
8 of 13 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 27, 2014 Reel 32054, frame 773 | Brister, Mark C.; Faucher, Paul D.; Drake, Neil R.; Rasdal, Andrew P.; Lake, Matthew S.; Markovic, Dubravka; Vandenberg, Amy D.l.; Llevares, Antonio C.; Nider, Josefina | Obalon Therapeutics Inc. | Assignment of Assignor's Interest |
| Oct 6, 2021 Reel 57726, frame 716 | Obalon Therapeutics, Inc. | Reshape Lifesciences Inc. | Change of Name |
| Oct 24, 2024 Reel 70166, frame 882 | Reshape Lifesciences Inc. | Ascent Partners Fund LLC | Security Interest |
| Sep 23, 2025 Reel 72955, frame 766 | Reshape Lifesciences Inc. | Medtimo Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Citations
37
later US patents cite this one
That is top 25% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.